Myo‐inositol vs clomiphene
It is very uncertain whether myo‐inositol changes adverse event ‐ multiple pregnancy compared with an ovulation induction agent (clomiphene) (very low certainty).
- OR 0.21 [0.01, 4.43]1 study · 75 participantsVery low
It is very uncertain whether myo‐inositol changes adverse event ‐ multiple pregnancy compared with an ovulation induction agent (clomiphene) (very low certainty).
Myo‐inositol showed no clear difference in adverse event ‐ multiple pregnancy compared with placebo, no/standard treatment (low certainty).
It is very uncertain whether myo‐inositol changes adverse event ‐ multiple pregnancy compared with antioxidant (melatonin) (very low certainty).
It is very uncertain whether coasting changes multiple pregnancy compared with gonadotrophin‐releasing hormone antagonist (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Coasting may leads to lower multiple pregnancy compared with no coasting (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether HMG FET changes multiple pregnancy rate per woman compared with clomiphene + HMG FET (very low certainty).
It is very uncertain whether natural cycle FET changes multiple pregnancy rate per woman compared with HT FET (very low certainty).
Natural cycle FET showed no clear difference in multiple pregnancy rate per woman compared with HT plus GnRHa suppression FET (low certainty).
It is very uncertain whether glucocorticoid supplementation changes multiple pregnancy rate per woman/couple compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Combined oral contraceptive pill showed no clear difference in multiple pregnancy rate (COCP + Ant vs Ant) compared with no pretreatment (low certainty).
Metformin showed no clear difference in multiple pregnancy rate (per woman) compared with placebo co‐treatment (low certainty).